Is Clinical Radiosensitivity a Complex Genetically Controlled Event?
暂无分享,去创建一个
Umberto Ricardi | Pierfrancesco Franco | P. Franco | U. Ricardi | A. Filippi | Andrea Riccardo Filippi
[1] M. Spitz,et al. From genotype to phenotype: correlating XRCC1 polymorphisms with mutagen sensitivity. , 2003, DNA repair.
[2] S. Kumar,et al. TGF‐β1 levels in pre‐treatment plasma identify breast cancer patients at risk of developing post‐radiotherapy fibrosis , 1999, International journal of cancer.
[3] C. Arlett,et al. Four radiation hypersensitivity cases and their implications for clinical radiotherapy. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] R. Stock,et al. ATM mutations in female breast cancer patients predict for an increase in radiation-induced late effects. , 2002, International journal of radiation oncology, biology, physics.
[5] J. Todd,et al. Strategies in complex disease mapping. , 2000, Current opinion in genetics & development.
[6] A. Rosenthal,et al. Clinical Investigation , 2003, Advances in Experimental Medicine and Biology.
[7] T. Ohnishi,et al. In vitro and in vivo potentiation of radiosensitivity of malignant gliomas by antisense inhibition of the RAD51 gene. , 1998, Biochemical and biophysical research communications.
[8] R. Bristow,et al. Mutant p53 increases radioresistance in rat embryo fibroblasts simultaneously transfected with HPV16-E7 and/or activated H-ras. , 1994, Oncogene.
[9] M. Fernet,et al. Genetic biomarkers of therapeutic radiation sensitivity. , 2004, DNA repair.
[10] M. Gatei,et al. An anti-sense construct of full-length ATM cDNA imposes a radiosensitive phenotype on normal cells , 1998, Oncogene.
[11] Yusuke Nakamura,et al. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. , 2002, Neoplasia.
[12] J. Chang-Claude,et al. Studies on radiosensitivity from an epidemiological point of view - overview of methods and results. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] T. Stankovic,et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. , 1997, British Journal of Cancer.
[14] K. Weber,et al. Trans-dominant inhibition of poly(ADP-ribosyl)ation leads to decreased recovery from ionizing radiation-induced cell killing. , 1998, International journal of radiation biology.
[15] P. Schlag,et al. BRCA1 and BRCA2– breast cancer susceptibility genes , 2000, Journal of Cancer Research and Clinical Oncology.
[16] A. Kiltie,et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. , 2000, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[17] J. Overgaard,et al. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] P. Jeggo,et al. Normal cellular radiosensitivity in an adult Fanconi anaemia patient with marked clinical radiosensitivity. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[19] D. Cox,et al. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. , 2003, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[20] R. Clarke,et al. Absence of ATM truncations in patients with severe acute radiation reactions. , 1998, International journal of radiation oncology, biology, physics.
[21] J. Lamerdin,et al. Rare microsatellite polymorphisms in the DNA repair genesXRCC1, XRCC3 andXRCC5 associated with cancer in patients of varying radiosensitivity , 1997, Somatic cell and molecular genetics.
[22] M. Southey,et al. Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. , 2000, International journal of radiation oncology, biology, physics.
[23] B. Alter. Radiosensitivity in Fanconi's anemia patients. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] J. Peacock,et al. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed. , 2003, International journal of radiation oncology, biology, physics.
[25] G. de Murcia,et al. Poly(ADP-ribose) polymerase: a molecular nick-sensor. , 1994, Trends in biochemical sciences.
[26] D. Hallahan,et al. c-jun and Egr-1 Participate in DNA Synthesis and Cell Survival in Response to Ionizing Radiation Exposure (*) , 1995, The Journal of Biological Chemistry.
[27] J. Overgaard,et al. Does variability in normal tissue reactions after radiotherapy have a genetic basis--where and how to look for it? , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[28] J. M. Murcia,et al. Poly(ADP-ribose) polymerase: a molecular nick-sensor. , 1994, Trends in biochemical sciences.
[29] D. Evans,et al. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? , 1999, American journal of human genetics.
[30] D. Cox,et al. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. , 2003, Cancer research.
[31] S. Seal,et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. , 1998, British Journal of Cancer.
[32] P. Vaupel,et al. Can erythropoietin improve tumor oxygenation? , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[33] C. Belka,et al. Clinical impact of predictive assays for acute and late radiation morbidity. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[34] J. Hoeijmakers,et al. Disruption of Mouse RAD54 Reduces Ionizing Radiation Resistance and Homologous Recombination , 1997, Cell.
[35] M. Swift,et al. Radiosensitivity of normal tissues in ataxia-telangiectasia heterozygotes. , 1998, International journal of radiation oncology, biology, physics.
[36] M. Meyn,et al. Human fibroblasts transfected with an ATM antisense vector respond abnormally to ionizing radiation. , 1999, International journal of molecular medicine.
[37] A. Begg,et al. Genetic manipulation of radiosensitivity. , 2001, International journal of radiation oncology, biology, physics.
[38] P. Jeggo,et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient , 1999, Current Biology.
[39] S. Powell,et al. The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. , 2002, Seminars in radiation oncology.
[40] R. Gatti. The Inherited Basis of Human Radiosensitivity , 2001, Acta oncologica.
[41] M. Villalobos,et al. Individualization of radiotherapy in breast cancer patients: possible usefulness of a DNA damage assay to measure normal cell radiosensitivity. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[42] R. Tibshirani,et al. Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[43] R. Houlston,et al. Variation in the manganese superoxide dismutase gene (SOD2) is not a major cause of radiotherapy complications in breast cancer patients. , 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[44] M. Lavin,et al. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[45] M. West,et al. XRCC1 keeps DNA from getting stranded. , 2000, Mutation research.
[46] R. Simon,et al. Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[47] P. Jeggo. DNA repair: PARP – another guardian angel? , 1998, Current Biology.
[48] S. Roberts,et al. Heritability of chromosomal radiosensitivity in breast cancer patients: a pilot study with the lymphocyte micronucleus assay. , 2000, International journal of radiation biology.
[49] G. Mills,et al. Evidence of haplotype insufficiency in human cells containing a germline mutation in BRCA1 or BRCA2 , 2002, International journal of cancer.
[50] Z. Ronai,et al. Expression of dominant negative CREB reduces resistance to radiation of human melanoma cells. , 1996, Oncogene.
[51] A. Hajeer,et al. Association of transforming growth factor beta-1 single nucleotide polymorphisms with radiation-induced damage to normal tissues in breast cancer patients , 2003, International journal of radiation biology.
[52] M. Southey,et al. Novel DNA sequence variants in the hHR21 DNA repair gene in radiosensitive cancer patients. , 2001, International journal of radiation oncology, biology, physics.
[53] W. Park,et al. Identification of radiation-specific responses from gene expression profile , 2002, Oncogene.
[54] M. Meyn. Ataxia‐telangiectasia, cancer and the pathobiology of the ATM gene , 1999, Clinical genetics.